End Cash: The amount of cash held by the company for the given period.
Cabaletta Bio, Inc. (CABA) had End Cash of $225.10M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-51.02M |
|
-- |
|
-- |
|
$52.02M |
|
$-52.02M |
|
$1.00M |
|
$-51.02M |
|
$-51.02M |
|
$-51.02M |
|
$-51.02M |
|
$-51.02M |
|
$-51.02M |
|
$-52.02M |
|
$-51.55M |
|
151.16M |
|
151.16M |
|
$-0.34 |
|
$-0.34 |
|
| Balance Sheet Financials | |
$231.03M |
|
$1.48M |
|
$25.70M |
|
$256.73M |
|
$39.91M |
|
-- |
|
$6.22M |
|
$46.13M |
|
$210.59M |
|
$210.59M |
|
$210.59M |
|
167.73M |
|
| Cash Flow Statement Financials | |
$-84.08M |
|
$50.96M |
|
$175.25M |
|
$82.98M |
|
|
End Cash |
$225.10M |
$142.12M |
|
$10.76M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.79 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-84.08M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-24.23% |
|
-24.23% |
|
-19.87% |
|
-24.23% |
|
$1.26 |
|
$-0.56 |
|
$-0.56 |
|